Avonex

The company's flagship product, another MS drug called Avonex, also delivered lackluster performance as revenue dropped from the fourth quarter despite price increases.

Biogen Earnings Fall on Health-Care Charges 2010

Biogen's flagship product, another MS drug called Avonex, reported strong sales in the quarter, rising 6% to $628 million and beating expectations of $597 million.

Biogen Net More Than Doubles on Higher Sales 2010

Any buyer will be getting one of the pioneers of the biotech industry, with extensive expertise in manufacturing proteins and a cash-generating drug, Avonex, that is the top-selling medicine for multiple sclerosis.

Biogen Gets a Dose of Skepticism 2007

Tysabri, an immune-modulating drug for multiple sclerosis, was voluntarily withdrawn from the market earlier this year after two patients taking it with another medication called Avonex developed an additional neurodegenerative disease, this one caused by a latent virus most of us harbor.

QUIETING A BODY'S DEFENSES 2007

The companies said the decision to withdraw the drug came after recent reports of two cases of serious effects among patients who used it along with an earlier Biogen Idec ( BIIB ) MS drug, called Avonex, in clinical trials The Food and Drug Administration approved Tysabri, which was called Antegren during clinical trials, in an accelerated process after a late-stage study showed that it reduced MS relapses by 66 percent compared with a placebo.

XM Raises Prices and Stakes 2005

So for example, to target MS doctors, we look at products such as Avonex or (inaudible) or

Biotech Sector and Stocks Analysis from Seeking Alpha 2010

She has had to scale back her work load due to pain and she can’t get hot because heat aggravates the MS. Her medication for Avonex which is an injection to take weekly to slow the progression is going to cost more than $300.00 weekly to fill.

Obama Policy Advisors on the Blog – Economic Security for Women | Barack Obama | positively Barack 2008

The medicine competes with injected drugs including Biogen Idec 's Avonex and Teva Pharmaceutical Industries' Copaxone.

EU Regulator Reviews Novartis MS Pill Sten Stovall 2012

Avonex, made by Biogen Idec Inc., required weekly intramuscular injections.

Pills Offer Easier Way to Treat MS Thomas Gryta 2011

By comparison, Avonex, one of the leading injectable drugs, has been shown to reduce MS flare-ups by 32% and disability progression by 37% over two years.

Pills Offer Easier Way to Treat MS Thomas Gryta 2011